Brazilian study checks if triple inhaler helps severe COPD patients breathe easier
Disease control
Recruiting now
This study follows about 400 adults with severe or very severe COPD in Brazil who are already using the Trimbow inhaler. Researchers will track their symptoms and lung function over 6 months to see how well the medication controls the disease. The study does not provide the drug—…
Sponsor: Chiesi Farmaceutica Ltda. • Aim: Disease control
Last updated May 17, 2026 15:08 UTC